GlassScriptPhysician profile
Steven Sandoval
NPI 1366466815
$14,416.27
in general payments reported to CMS, 2019-2025
7 companies · $6,578 in 2025
The $6,578 reported for 2025 was more than what 91% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $47.46 · 2024: $7,599 · 2025: $6,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,300 · Honoraria: $6,175 · Travel and Lodging: $377 · Food and Beverage: $175 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,300.00 |
| Honoraria | $6,175.00 |
| Travel and Lodging | $377.15 |
| Food and Beverage | $174.61 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $14,002.15 | 2024-2025 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Avita Medical Americas, LLC | $193.67 | 2019-2025 | Recell, Permeaderm, Cohealyx |
| Smith+Nephew, INC. | $104.52 | 2024 | Oasis |
| Acell, INC. | $67.94 | 2019-2020 | |
| Acera Surgical, INC. | $19.10 | 2024 | Restrata Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $16.19 | 2025 | |
| Merck Sharp & Dohme LLC | $12.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Sandoval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.